Vaxxinity Appoints Peter Powchik, M D , to Executive Vice President, Global Scientific Director tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Appointment adds Dr. Powchik’s experience in the development of marketed immunotherapeutics to Vaxxinity’s leadership team CAPE CANAVERAL, Fla., July 27,.
Vaxxinity Appoints Peter Powchik, M D , to Executive Vice President, Global Scientific Director marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Disease-modifying candidate UB-312 demonstrated target engagement of aggregated alpha-synuclein in cerebrospinal fluid of Parkinson’s patients Data provide validation of the Vaxxinity platform’s.
Blue Zone Wealth Advisors LLC acquired a new position in shares of Vaxxinity, Inc. (NASDAQ:VAXX – Free Report) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 27,500 shares of the company’s stock, valued at approximately $62,000. A number of other institutional investors and hedge funds […]